Skip to main content
Domainex
  • About
    • About
    • Track Record
    • Case Studies
    • Testimonials
    • Awards & Accreditations
    • Our team
    • Board members
    • Investors
    • Contact us
  • Solutions
    • Services
      • Biosciences
        • ADME and Bioanalytical Sciences
        • Assay Development and Transfer
        • Biochemistry / Enzymology
        • Biophysics
        • Cellular Biology
        • Compound screening and cascade design
        • Cryo-EM
        • Project Management and Consultancy Services
        • Protein Expression
        • Structural Biology
        • X-ray Crystallography
      • Chemistry
        • Analytical Chemistry
        • Direct-to-Biology (D2B)
        • Medicinal Chemistry
        • Synthetic Chemistry
      • Integrated Drug Discovery
        • Fragment based drug discovery
        • Hit to Lead
        • Hit Identification
        • Lead Optimisation
        • Project Management and Consultancy Services
        • Structure Based Drug Design (SBDD)
        • Lead Discovery
      • Computer Aided Drug Design
        • Computational Chemistry and Biology
        • Virtual Screening
      • Hit Identification
        • Fragment Screening
        • High Throughput Screening
        • Virtual Screening
    • Target Classes and Modalities
      • Biotherapeutics
      • Covalent Inhibitors
      • GPCRs
      • Ion Channels
      • Kinases
      • Methyltransferases
      • Molecular Glues
      • Prodrugs
      • Proteases
      • Protein-Protein Interactions
      • Targeted Protein Degradation
    • Therapeutic Areas
      • Anti-infectives
      • Cardiovascular
      • CNS
      • Immuno-Oncology
      • Inflammatory diseases
      • Oncology
      • Respiratory
    • A-Z
      • A
        • Aldehyde Oxidase Stability Assay
        • Analytical Chemistry
        • Anti-infectives
        • Assay Development and Transfer
      • B
        • Biochemistry / Enzymology
        • Biophysics
        • Biotherapeutics
      • C
        • CDH (Target Gene Fragmentation)
        • CNS
        • Caco-2 Permeability Assay
        • Cardiovascular
        • Cellular Biology
        • Compound screening and cascade design
        • Computational Chemistry and Biology
        • Covalent Inhibitors
        • Cryo-EM
      • D
        • Differential Scanning Fluorimetry (DSF) and nanoDSF Services
        • Direct-to-Biology (D2B)
        • Dynamic Light Scattering (DLS)
      • E
        • Experimental Polar Surface Area (EPSA) Assay
      • F
        • Flow Cytometry
        • Fragment based drug discovery
      • G
        • GPCRs
        • GSH Reactivity Assay
      • H
        • Hepatocyte Clearance/Stability Assay
        • High Throughput Screening
        • Hit Identification
        • Hit to Lead
      • I
        • Immuno-Oncology
        • Inflammatory diseases
        • Innovative Polymer Lipid Particle (PoLiPa) Technology
        • Integrated Drug Discovery
        • Ion Channels
        • Isothermal Titration Calorimetry (ITC)
      • K
        • Kinact / KI Assay for Irreversible Covalent Compounds
        • Kinases
      • L
        • Lead Optimisation
        • Ligand binding assays by Surface Plasmon Resonance (SPR) and/or Grating-Coupled Interferometry (GCI)
      • M
        • Medicinal Chemistry
        • Membrane protein production
        • Methyltransferases
        • Microsomal Clearance/Stability Assay
        • Molecular Glues
      • N
        • Neuroinflammation
      • O
        • Oncology
      • P
        • Photoaffinity Labelling
        • Plasma Protein Binding Assay
        • Plasma Stability Assay
        • Project Management and Consultancy Services
        • Proteases
        • Protein Expression
        • Protein-Protein Interactions
      • R
        • Respiratory
        • Reversible Covalent Inhibitor Binding Assay
      • S
        • Shake Flask LogD
        • Spectral Shift and MST Services
        • Structural Biology
        • Structure Based Drug Design (SBDD)
        • Synthetic Chemistry
      • T
        • Targeted Protein Degradation
        • Targeted Protein Degrader Toolbox
        • Ternary Complex Formation Assays
        • Thermodynamic Solubility Assay
        • Turbidimetric (Kinetic) Solubility Assay
      • V
        • Virtual Screening
      • X
        • X-ray Crystallography
  • Library
    • Articles
    • Brochures
    • Newsletters
    • Posters
    • Presentations & Videos
    • Publications
    • White Papers
    • Webinars
  • News & Events
  • Careers
  • English
  • French
  • Spanish
  • German
  • Italian
  • Japanese
  • Dutch
  • USA
Enquire

News & Events

News

Domainex and Pharmacelera Join Forces to Accelerate Discovery of Molecules Targeting Transmembrane Proteins

27 Aug '25
Press Release

Domainex Appoints Hayley French as Chief Executive Officer

7 May '25
Press Release

Nuclera’s eProtein Discovery system installed at Domainex to streamline protein production services

4 Nov '24
Press Release
View more

Articles

New Predictive Tools for CADD: SMID, 3DPSA, and pKBHX for Smarter Drug Design

12 Sep '25
Blog Post

Trek to Remember

22 Aug '25
Blog Post

Synthesis in Review: Photochemical Skeletal Editing - Atom Swapping and Carbon Deletion in Indoles, Benzofurans, and Azaarenes

12 Aug '25
Blog Post
View more

Events

Sep 21 Fragment-Based Lead Discovery Conference

Sep 22 Discovery on Target 2025

Nov 12 BMCS New approaches to the treatment of Parkinson’s

View more
Newsletter image

Sign up to receive the Domainex newsletter

Join our mailing list to receive the latest news from Domainex. Our regular newsletter includes all our latest updates, new service launches, recent publications, awards, team news and upcoming events.

Start your next project with Domainex

Contact one of our experts today
Domainex

+44(0) 1223 433180 enquiries@domainex.co.uk

Cyber Essentials - Certified Plus

Domainex is a registered company (number 4336899)

Site and its contents Copyright © Domainex 2025. All rights reserved.

Terms and Conditions | Privacy Policy